OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Applied Clinical Trials
Synteract, a full-service, Phase I-IV CRO announced the creation of therapeutic centers of development that include oncology, especially leading edge immunotherapy studies, neuro-degenerative disorders, pediatrics, and rare and orphan disease.
Read the full release here.
Related Content:
News